• Himani Joshi Department of Pharmacology, Faculty of Pharmacy, Jamia Hamdard, New Delhi
  • Uma Bhandari Department of Pharmacology, Faculty of Pharmacy, Jamia Hamdard, New Delhi
  • Bibhu Prasad Panda Department of Pharmaceutical Biotechnology, Faculty of Pharmacy, Jamia Hamdard, New Delhi


Objective: The present study was focused on assessing the antimicrobial activity of curcumin against Providencia rettgeri, a gut microbe, which was further corelated to the effect of curcumin on choline metabolism and its role in preventing atherosclerosis and on the evaluation of potential of curcumin on the inhibition of conversion of choline to trimethylamine (TMA), and further its conversion to trimethylamine-N-oxide (TMAO) in liver.

Methods: The minimum inhibitory concentration of curcumin was determined using Cup-plate method. The estimation of trimethylamine was performed using high performance thin layer chromatography (HP-TLC) technique. Estimation of blood serum parameters were performed using kits supplied by Span-diagnostics for estimation of triglycerides, total cholesterol and high density lipoprotein (HDL) cholesterol. All surgical procedures on animals including blood withdrawal and isolation of livers were carried out in accordance with CPCSEA guidelines.

Results: The minimum inhibitory concentration of curcumin was found to be 10 µg/ml. There was a significant increase (p<0.001) in the mean triglyceride, total cholesterol, low-density and very low-density lipoprotein, along with a significant decrease (p<0.001) in high-density lipoprotein in choline-fed mice. Also, there was significant decrease (p<0.001) in the mean triglyceride, total cholesterol, low-density and very low-density lipoprotein, along with a significant increase (p<0.001) in high-density lipoprotein cholesterol in choline-fed mice treated with curcumin. Further, there was a decrease in the Flavin mono-oxygenase (FMO3) activity in the mice livers treated with curcumin by 21.57%.

Conclusion: It was concluded that curcumin has the potential to inhibit gut microbiota thus prevention the conversion of choline to trimethylamine, has serum lipid lowering effect in female C57BL/6J mice and has an inhibitory effect on hepatic FMO3 thus preventing the conversion of trimethylamine to trimethylamine-N-oxide.

Keywords: Choline, Trimethylamine, Trimethylamine-N-oxide, Curcumin, FMO3, Providencia rettgeri, C57BL/6J mice


Download data is not yet available.


1. Wang Z, Klipfell E, Bennett B, Koeth R, Levison B, DuGar B, et al. Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease. J Nat 2011;472:57-65.
2. Al-Waiz M, Mikov M, Mitchell SC, Smith RL. The exogenous origin of trimethylamine in the mouse. J Metabol 2007;41:135–6.
3. DaCosta KA, Vrbanac JJ, Zeisel SH. The measurement of dimethylamine, trimethylamine trimethylamine-N-oxide using capillary gas chromatography-mass spectrometry. J Anal Biochem 1990;187:234-9.
4. Lang DH, Yeung CK, Peter RM, Ibarra C, Gasser R, Itagaki G, et al. Isoform specificity of trimethylamine N-oxygenation by human flavin-containing monooxygenase (FMO) and P450 enzymes: selective catalysis by fmo3. Biochem Pharmacol 1998;56:1005–12.
5. Mitchell SC, Smith RL. Trimethylaminuria: the fish malodor syndrome. Drug Metab Dispos 2001;29:517–21.
6. Schadt EE, Lamb J, Yang X, Zhu J, Edwards S, Guhathakurta D, et al. An integrative genomics approach to infer causal associations between gene expression and disease. Nature Genet 2005;37:710–7.
7. Koeth RA, Wang Z, Levison BS, Buffa JA, Org E, Sheehy B, et al. Intestinal microbiota metabolism of L-carnitine, a nutrient red meat, promotes atherosclerosis. J Nat Med 2013;19:576-85.
8. Jawein J. Mouse experimental models of atherosclerosis in pharmacology. J Clin Exp Cardiol 2011;10:211-55.
9. Tang W, Wang Z, Levison B, Koeth R, Britt E, Fu X, et al. Intestinal microbial metabolism of phosphatidylcholine and cardiovascular disease. New Eng J Med 2013;369:1575-84.
10. Rudrappa T, Bais HP. Curcumin, a known phenolic from Curcuma longa, attenuates the virulence of Pseudomonas aeruginosa PAO1 in whole plant and animal pathogenicity models. J Agric Food Chem 1962;56:200.
11. Lee CJ, Lee JH, Seok GH, Hur GM, Park YC, Seol IC, et al. Effects of baicalein, berberine, curcumin and hespiridin on mucin release from airway goblet cells. J Plant Med 2003;69:523–6.
12. Shukla Y, Arora A. Suppression of altered hepatic foci development by curcumin in Wistar rats. J Nutr Cancer 2003;45:53–9.
13. Jentzsch K, Gonda T, Holler H. Paper chromatographic and pharmacological investigations on curcuma pigments. Pharm Acta Helvitiae 1959;34:181–8.
14. Patel K, Srinivasan K. Influence of dietary spices and their active principles on pancreatic digestive enzymes in albino rats. Nahrung 2000;44:42–6.
15. Nirmala C, Puvanakrishnan R. Protective role of curcumin against isoproterenol-induced myocardial infarction in rats. J Mol Cell Biol 1996;159:85–93.
16. Brouet I, Ohshima. Curcumin, an antitumor promoter and anti-inflammatory agent, inhibits induction of nitric oxide synthase in activated macrophages. Biochem Biophy Res Comm 1995;206:533–40.
17. Srimal RC, Dhawan BN. In development of unani drugs from herbal sources and the role of elements in their mechanism of Action. Hamdard National Foundation Monograph: New Delhi; 1985. p. 256.
18. Sharma OP. Antioxidant activity of curcumin and related compounds. J Biochem Pharmacol 1976;25:1811–2.
19. Chen HW, Huang HC. Effect of curcumin on cell cycle progression and apoptosis in vascular smooth cells. Br J Pharmacol 1998;124:1029–40.
20. Piedrahita JA, Zhang SH, Hagaman JR, Oliver PM, Maeda N. Generation of mice carrying a mutant apolipoprotein E gene inactivated by gene targeting in embryonic stem cells. Proc Natl Acad Sci USA Genetics 1992;89:4471-5.
21. Subhapriya S, Tomi L, Padmanaban VC. Atherosclerosis: critical role of oxidation and inflammation. Int J Pharm Pharm Sci 2013;5:6-7.
22. Olszanecki R, M Jawien J, Gajda M, Mateuzuk L, Gebska A, Korabiowska M, et al. Effect of curcumin on atherosclerosis in apoE/lDLR-double knockout mice. J Physiol Pharmacol 2005;56:627-35.
23. Nakashima Y, Plump AS, Raines EW, Breslow JL, Ross R. ApoE-deficient mice develop lesions of all phases of atherosclerosis throughout the arterial tree. Arterioscler Thromb 1994;14:133-40.
24. Kapakos G, Youreva V, Srivastava AK. Cardiovascular protection by curcumin. Indian J Biochem Biophys 2012;49:306-15.
25. Rose SB, Miller RE. Studies with agar cup plate method. J Bacteriol 1939;38:246-54.
26. Demacher PN, Hijamaus AG, Janssen HE, Laar A, Jansen AP. A study of the use of polyethylene glycol in estimating cholesterol. J Clin Chem 1980;26:1775–8.
27. Foster LB, Dunn RT. Stable reagents for the determination of serum triglycerides by colorimetric Hantzch condensation method. J Clin Chem 1973;19:338-40.
28. Burstein M, Scholnick HR, Morfix R. Rapid method for isolation of lipoproteins from human serum by precipitation with polyanions. J Lipid Res 1970;11:583-95.
29. Friedwald WT, Levy RI, Friedrick DS. Estimation of the concentration of Low-density Lipoprotein Cholesterol without use of preparative ultracentrifuge. J Clin Chem 1972;18:499-502.
30. Dobiasova M, Frohlich J. The plasma parameter log (TG/HDL-C) as an atherogenic index: correlation with lipoprotein particle size and esterification rate in apoB-lipoprotein-depleted plasma (FERHDL). J Clin Biochem 2001;34:583-8.
31. Kamath SA, Kummerow FA, Narayan KA. A simple procedure for the isolation of rat liver microsomes. Fed Eur Biochem Soc Lett 1971;17:90-2.
256 Views | 1204 Downloads
How to Cite
Joshi, H., U. Bhandari, and B. P. Panda. “TO ASSESS THE POTENTIAL OF CURCUMIN AGAINST GUT MICROBIOTA-INDUCED ALTERATION IN CHOLINE METABOLISM IN C57BL/6J MICE”. International Journal of Pharmacy and Pharmaceutical Sciences, Vol. 9, no. 3, Feb. 2017, pp. 215-26, doi:10.22159/ijpps.2017v9i3.15966.
Original Article(s)